1.14 USD
▼-0.03-2.91%
盘后 1.28 0.00%
2026-09-16
市值
$14.07M
市盈率
—
EPS
-2.44
股息率
—
52 周区间
1.12 – 4.96
成交量
26.94K
Beta
0.67
目标价
—
52W 低 1.1252W 高 4.96
价格走势
公司简介
Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and an immunotherapy platform. Its product candidates include PLX-PAD, which is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle...